MARSHALL WACE, LLP - INARI MED INC ownership

INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 186 filers reported holding INARI MED INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of INARI MED INC
ValueSharesWeighting
Q3 2023$30,339,517
+98.0%
463,907
+76.0%
0.06%
+103.3%
Q2 2023$15,324,309
-37.2%
263,576
-33.3%
0.03%
-42.3%
Q1 2023$24,414,033
+1360.2%
395,433
+1964.9%
0.05%
+477.8%
Q4 2020$1,672,00019,1500.01%
Other shareholders
INARI MED INC shareholders Q1 2021
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 125,000$11,409,0004.14%
SECTORAL ASSET MANAGEMENT INC 163,550$14,927,0002.25%
Lisanti Capital Growth, LLC 81,460$7,435,0001.08%
Pier Capital, LLC 99,422$9,074,0000.96%
Beck Bode, LLC 33,384$3,047,0000.76%
Nicholas Investment Partners, LP 104,932$9,577,0000.61%
CNA FINANCIAL CORP 24,773$2,261,0000.59%
NEXT CENTURY GROWTH INVESTORS LLC 56,523$5,158,0000.46%
HARBOURVEST PARTNERS LLC 38,540$3,518,0000.45%
Birchview Capital, LP 7,000$639,0000.41%
View complete list of INARI MED INC shareholders